華陽國際(002949.SZ):上半年淨利預增56.5%-73.1%
格隆匯7月14日丨華陽國際(002949.SZ)披露2021年半年度業績預吿,預計上半年歸屬於上市公司股東的淨利潤6150萬元–6800萬元,比上年同期增長56.5%-73.1%。基本每股收益0.31元/股–0.35元/股。
受疫情影響,公司2020年一季度經營虧損,導致2020年上半年利潤增速放緩。隨着疫情得到有效控制,2021年上半年公司經營狀況平穩,各業務板塊收入同比增長較快,報吿期內歸屬於上市公司股東的淨利潤較上年同期有較大增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.